Caesars ENT

Forecast & Rating15 analysts currently cover Caesars ENT, with about 6.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $31.27, about 5.3% upside from the current price of $29.69. Price targets are fairly clustered, pointing to relatively aligned views. Historically, about 7.9% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Caesars ENT's outlook. Data as of Aug 18, 2026; for reference only and not investment advice.